MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0156456
Zaria Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.69 Cr
▼ 20% YoY
Net loss · FY 2025
₹1.23 Lakh
Net margin -0.5%
EBITDA · FY 2025
₹27.48 Lakh
EBITDA margin 10.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.21 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
17
Provident fund records
About Zaria Pharmaceuticals Private Limited
Data last updated:
Zaria Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2018PTC315946. Its GSTIN is 27AABCZ2750N1ZW (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.21 Lakh. It is led by directors Satya Prakash Pandey and Sneha Satyaprakash Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 604 & 606 Quantam IT Park Plot No. B – 68 Wagle Estate Thane West, Maharashtra, India – 400604.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.69 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹1.23 Lakh (net margin -0.5%) and EBITDA of ₹27.48 Lakh (EBITDA margin 10.2%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 8% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Zaria Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0156456). For more details, the company can be reached via its website zariapharma.com.
Company details
CIN U51909MH2018PTC315946
Registration Number 315946
Incorporation Date 17 October 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-MH-33-0156456
Recognitions & Rankings of Zaria Pharmaceuticals
Contact details
Zaria Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is zariapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 604 & 606 Quantam IT Park Plot No. B – 68 Wagle Estate Thane West, Maharashtra, India – 400604
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zaria Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Zaria Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Zaria Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zaria Pharmaceuticals Private Limited, buy the company report.
Financials of Zaria Pharmaceuticals Private Limited
FY 2025 filings availableZaria Pharmaceuticals Private Limited reported revenue of ₹2.69 Cr (down 20% YoY) for FY 2025.
Revenue · FY 2025
₹2.69 Cr ▼ 20%
Net loss · FY 2025
₹1.23 Lakh margin -0.5%
EBITDA · FY 2025
₹27.48 Lakh margin 10.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 20%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 7%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 20% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.48 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zaria Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zaria Pharmaceuticals Private Limited
Zaria Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satya Prakash Pandey | Director | 17 Oct 2018 | 8 Years 0 Months | Current |
| Sneha Satyaprakash Pandey | Director | 17 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Zaria Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Andromeda Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2025) | 26.0% | Indore, Madhya Pradesh, India | |||
| Medicure Formulations Private Limited | ₹2.69 Cr (FY 2025) | 22.0% | Thane, Maharashtra, India | |||
| Zaria Pharmaceuticals Private Limitedthis company | ₹2.69 Cr (FY 2025) | -₹1.23 Lakh | -0.5% | -20.0% | 17 | Thane, Maharashtra, India |
| Med-Esales Life Sciences Private Limited | ₹2.68 Cr (FY 2025) | -1.0% | Agra, Uttar Pradesh, India | |||
| Synoglad Pharmaceuticals Private Limited | ₹2.67 Cr (FY 2016) | 8.0% | Jaipur, Rajasthan, India | |||
| Cnscure India Private Limited | ₹2.67 Cr (FY 2024) | 184.0% | Delhi, India | |||
| Sois Formulations Private Limited | ₹2.67 Cr (FY 2025) | -23.0% | Ambala Cantt, Haryana, India | |||
| Rangwani Pharmaceuticals Private Limited | ₹2.67 Cr (FY 2024) | 16.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Zaria Pharmaceuticals Private Limited, buy the company report.
Auditor
Zaria Pharmaceuticals Private Limited is audited by C A G K AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C A G K AND CO | FY 2023 | 152566W |
Shareholding
The shareholding of Zaria Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zaria Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Aug 2020 | 100364737 | State Bank of India | ₹1 Cr | Open |
To see the full charge records of Zaria Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Zaria Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by an individual | Pending |
To see the full case history of Zaria Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zaria Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Zaria Pharmaceuticals Private Limited has a workforce of 17 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
17
Active EPFO establishments
1
Employee growth
-43.33%
GST
Zaria Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCZ2750N1ZW | Maharashtra | Active | 29 Oct 2018 |
To see the full GST registrations and return filing status of Zaria Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zaria Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Satya Prakash Pandey was appointed as Director on 17 Oct 2018.
AGM
Zaria Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zaria Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with State Bank Of India of Rs. 100.00 Lakh registered on 31 Aug 2020 with Charge ID 100364737 was modified on 23 Aug 2023.
Charges
A charge with State Bank Of India amounted to Rs. 100.00 Lakh with Charge ID 100364737 was registered on 31 Aug 2020.
Appointed
Satya Prakash Pandey was appointed as Director.
Appointed
Sneha Satyaprakash Pandey was appointed as Director.
Incorporation
17 Oct 2018
Zaria Pharmaceuticals Private Limited was registered on 17 Oct 2018 with Roc Mumbai & aged 8 years 8 days as per MCA records.
Frequently asked questions
Zaria Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 October 2018 (8+ years old) and is registered under CIN U51909MH2018PTC315946.
Zaria Pharmaceuticals has 2 current directors:
- Satya Prakash Pandey - Director
- Sneha Satyaprakash Pandey - Director
The latest financial statements of Zaria Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Zaria Pharmaceuticals is 27AABCZ2750N1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of Zaria Pharmaceuticals is U51909MH2018PTC315946. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zaria Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Zaria Pharmaceuticals was incorporated on 17 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Zaria Pharmaceuticals by revenue are Andromeda Pharmaceuticals Private Limited, Medicure Formulations Private Limited, Med-Esales Life Sciences Private Limited, Synoglad Pharmaceuticals Private Limited, Cnscure India Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Satya Prakash Pandey was appointed as Director on 17 Oct 2018. Sneha Satyaprakash Pandey was appointed as Director on 17 Oct 2018.
Yes, Zaria Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0156456).
Zaria Pharmaceuticals can be reached through the website zariapharma.com. Its registered office is in Thane, Maharashtra, India.